Contact Us


Your Name (required)

Your Email (required)

Subject

Your Message

pharmaceutical serialization

WDSrx Experts Speak at Industry Conferences

Significant supply chain organizations have approached WDSrx to speak at prominent industry conferences about our logistics experience. “We always entertain requests from external sources to share our logistics expertise as it helps our current and potential clients understand the challenges that we address in our industry,” states WDSrx President Adam Runsdorf. Recently, WDSrx Marketing Director Larry Hotz participated in a panel discussion at the CSCMP 2018 Edge Conference in Nashv...

Manufacturers Rely On Logistics Services Providers For Complete Serialization

Manufacturers faced with the prospect of significant costs to meet the impending deadline for DSCSA compliance can achieve savings and peace-of-mind by outsourcing to serialization-ready third party logistics providers. Many pharmaceutical manufacturers choose not to make the significant investment to upgrade hardware, software, equipment and training for pharmaceutical serialization requirements.  In addition to realizing cost savings compared with outright equipment purchase, these programs a...

WDSrx Monthly News Update August 2017

WDSrx gets published on DC Velocity, sponsors an HDA Serialization Survey, attends NACDS this month and welcomes a new member of our business development team. Read our monthly update for details. ...

Serialization Implementation and Operations for DSCSA Compliance (updated July 2018)

SUMMARY With the stroke of a pen in 2013, the pharmaceutical industry mobilized in order to comply with sweeping changes enacted by the Drug Quality and Security Act. The law includes the Drug Supply Chain Security Act (“DSCSA”), written to increase patient safety by minimizing risk from unauthorized pharmaceutical drug products entering the marketplace.   The Food and Drug Administration, charged with enforcing the Act, set deadlines for the industry to comply with this law. The law requi...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.